Abstract
Acetyl-CoA carboxylase (ACC) is one of the more promising therapeutic targets for non-alcoholic steatohepatitis (NASH), but current ACC inhibitors alr......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
